Send feedback

MAP1B p.Ile1391Val

c.4171A>G · VCV3891619

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.0782 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000593%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
periventricular nodular heterotopia 9

Computational evidence

Protein change
AlphaMissense0.0782likely benign
REVEL0.141moderately benign-leaning
SaProtLLR -5.31tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 4.1GERP -0.11, phastCons 1
Regional constrainto/e 0.91unconstrained · MANE · 5,330 bp · p 1.3e-05 · regional, not allelic
Overall
CADD15.14PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000593% European (non-Finnish) · 7/1,180,040 alleles
Filtering AF 0.000247% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000159%
Overall 0.000496% 8/1,614,058 alleles · very rare exomes 7/1,461,868 · genomes 1/152,190 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0016% 62,486
European (non-Finnish)grpmax 0.000593% 168,577

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MAP1B
Protein
p.Ile1391Val
Coding
c.4171A>G
MANE Select
NM_005909
Type
single nucleotide variant
Location
chr5:72197526 (GRCh38)
Gene constraint
LOEUF 0.105 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 46.18
Residue 1391
a UniProt-annotated variant site (in pvnh9); a UniProt-annotated variant site (in pvnh9; no effect on protein expression); the 'disordered' region
Full MAP1B gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/map1b-p-ile1391val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown